152185-73-4Relevant academic research and scientific papers
Taxoid anti-tumor agents, pharmaceutical compositions, and treatment methods
-
, (2008/06/13)
A taxoid of formula (7), a method for making the taxoid, a pharmaceutical composition containing the taxoid, and a method for treating tumors by administering the taxoid: whereinR1 is a branched or unbranched C3-C5 alkyl o
Taxoid anti-tumor agents and pharmaceutical compositions thereof
-
, (2008/06/13)
Pharmaceutical compositions, methods of administration, and methods of treatment of cancer with new generation taxoids, of formulas (I) and (II), and derivatives thereof, are described:
Taxoid anti-tumor agents and pharmaceutical compositions thereof
-
, (2008/06/13)
Pharmaceutical compositions, methods of administration, and methods of treatment of cancer with new generation taxoids, of formulas (I) and (II), and derivatives thereof, are described: 1
Taxoid anti-tumor agents and pharmaceutical compositions thereof
-
, (2008/06/13)
This invention relates to a taxoid of the formula (I) wherein R1 is 1-propenyl radical; R2 is a C3-C5 branched alkyl radical; R3 and R4 are independently selected from hydrogen and hydroxyl protecting groups including functional groups which increase the
Taxoid anti-tumor agents and pharmaceutical compositions thereof
-
, (2008/06/13)
This invention relates to a taxoid of the formula (I): STR1 wherein R1 is a C3 -C5 alkyl or alkenyl or trifluoromethyl radical; R2 is a C3 -C5 branched alkyl radical; R3 and Rsu
Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment
-
, (2008/06/13)
The present invention is directed to novel taxanes useful as chemotherapeutic agents or their precursors. Processes for preparing the novel taxanes include coupling reactions, in the presence of a base, of baccatin of formula (III) or (IV) STR1 with β-lac
Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment
-
, (2008/06/13)
The present invention is directed to novel taxanes useful as chemotherapeutic agents or their precursors. Processes for preparing the novel taxanes include coupling reactions, in the presence of a base, of baccatin of formula (III) or (IV) STR1 with β-lac
